This case involves a 24-year-old woman who was approximately 6 weeks pregnant after using Bravelle, when she developed cramping and bleeding that prompted her to go to the ER. She was seen by an ER doctor who ordered an abdominal and vaginal ultrasound but never called an Ob/Gyn consultation. She was told that they found no signs of a viable fetus but that a normal heartbeat should not be expected at such an early stage of pregnancy. At the initial visit, she was given Rhogam and discharged home. The patient returned home and continued to bleed substantially to the point where she had no other option but to return to the ER. On this visit the ER, physicians again proceeded without an Ob/Gyn consult and determined that the patient had a miscarriage; no D&C was scheduled or discussed with the patient. One month later the patient began to hemorrhage and again returned to the hospital. An eventual Ob/Gyn consult informed her that she had a complete molar pregnancy and needed an immediate D&C. The patient was referred to an oncologist based on high HCG levels and she was then told she had uterine cancer.